$1.45 Billion is the total value of QVT Financial LP's 75 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | WELLPOINT INCnote 2.750%10/1 | $30,326,000 | – | 16,500,000 | +100.0% | 2.09% | – | |
| MU | New | MICRON TECHNOLOGY INCcall | $23,392,000 | – | 1,700,000 | +100.0% | 1.61% | – |
| New | WEBMD HEALTH CORPnote 2.500% 1/3 | $13,892,000 | – | 12,500,000 | +100.0% | 0.96% | – | |
| New | CTRIP COM INTL LTDnote 1.000% 7/0 | $13,723,000 | – | 13,000,000 | +100.0% | 0.94% | – | |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $10,894,000 | – | 2,047,782 | +100.0% | 0.75% | – |
| FIT | New | FITBIT INCcl a | $7,082,000 | – | 579,502 | +100.0% | 0.49% | – |
| MFRM | New | MATTRESS FIRM HLDG CORP | $4,386,000 | – | 130,738 | +100.0% | 0.30% | – |
| FRO | New | FRONTLINE LTD | $3,202,000 | – | 408,341 | +100.0% | 0.22% | – |
| ADRO | New | ADURO BIOTECH INC | $2,171,000 | – | 191,954 | +100.0% | 0.15% | – |
| SRLP | New | SPRAGUE RES LP | $964,000 | – | 39,979 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
| NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
| ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
| JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
| SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
| BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
| GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
| ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
| WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
| NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
| Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
| Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
| Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
| Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
| AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-03-07 |
| SC 13G/A | 2024-03-07 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-02 |
| 144 | 2023-09-28 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-05-18 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.